DUAL ANTIGEN - DATVAC

Diphtheria and Tetanus Vaccine (Adsorbed) I.P.

INDICATION

For the prevention of diphtheria and tetanus in children less than 7 years of age when pertussis antigens is contraindicated or should not be used.

ROUTE OF ADMINISTRATION

Intramuscular Injection

IMMUNIZATION SCHEDULE

  • First 3 doses of 0.5 ml each should be given 4 weeks apart and followed by fourth dose given approximately 6–12 months later

COMPOSITION

  • Each single 0.5 ml dose contains

  • Diphtheria Toxoid ≤ 25 Lf (≥ 30 IU)

  • Tetanus Toxoid ≥ 5 Lf (≥ 40 IU)

  • Adsorbed on Aluminium Phosphate, Al+++ ≤ 1.25 mg

  • Preservative: 0.005% Thiomersal

PRESENTATION:

  • Box of 10 ampoules of 0.5 ml each

DTPHHVAC SD/PFS

Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis B (rDNA) and Haemophilus Type b Conjugate Vaccine (Adsorbed) I.P.

INDICATION

For the prevention of serious childhood diseases: Diphtheria, Tetanus, Pertussis (whooping cough), Hepatitis B and Haemophilus Influenzae type b.

ROUTE OF ADMINISTRATION

Intramuscular Injection.

IMMUNIZATION SCHEDULE

First dose is given at 6 weeks or 10 weeks or 14 weeks of age

Second dose is given anytime between 12-18 months of age

COMPOSITION

  • Each dose of 0.5 ml contains

  • Diphtheria Toxoid ≤ 25 Lf (≥ 30 IU)

  • Tetanus Toxoid ≥ 2.5 Lf (≥ 40 IU)

  • B. pertussis (whole cell) ≤ 16 OU (≥ 4.0 IU)*

  • HBsAg (rDNA) ≥ 10 mcg

  • Purified capsular Hib Polysaccharide (PRP)

  • Conjugated to Tetanus Toxoid (carrier protein) 10 mcg

  • +++ Adsorbed on Aluminium Phosphate, Al ≤ 1.25 mg

  • Preservative: Thiomersal 0.005%

  • *The lower fiducial limit (P=0.95) of the estimated potency is not less than 2.0 IU. Adsorbed can be given at the age of 15-18 months.

PRESENTATION:

  • DTPHHVAC SD: 1 dose vial of 0.5 ml

  • DTPHHVAC PFS: 1 x 0.5 ml - 1 dose pre-filled syringe

HepaVAC-B

Hepatitis B Vaccine (rDNA) I.P.

INDICATION

Hepatitis B vaccine is indicated for active immunization against Hepatitis B infection in subjects considered at risk of exposure to HBV positive material.

ROUTE OF ADMINISTRATION

Intramuscular Injection.

IMMUNIZATION SCHEDULE

Pediatric dose vaccine: 10 mcg dose (in 0.5 ml suspension) is recommended for neonates, infants, children and adolescents up to 19 years of age.

Adult dose vaccine: 20 mcg dose (1.0 ml suspension) is recommended for adults aged 20 years and above

  • A series of 3 shots can prevent this serious disease

  • 6, 10, 14 weeks for infants

  • 0, 1, 6 months for children, adolescents and adults

  • 0, 1, 2 months (for rapid protection)

COMPOSITION

  • Each ml dose contains

  • Purified Hepatitis-B surface antigen 20 mcg

  • Adsorbed on Aluminium hydroxide, Al+++ ≤ 1.25 mg

  • Preservative: ≤ 0.01% Thiomersal

PRESENTATION:

  • Box of 10 ampoules of 0.5 ml each

  • Box of 10 ampoules of 1 ml each

  • Box of one 10 ml MD vial

RABIESVAC-F

Rabies Vaccine, Human I.P. (Freeze-dried)

RABIESVAC-F is indicated for the prevention of rabies in children and adults. It can be used before or after exposure, as a primary immunization or as a booster dose.

ROUTE OF ADMINISTRATION

Intramuscular & Intra-dermal.

IMMUNIZATION SCHEDULE

The following schedule should be followed for pre-exposure prophylaxis in high risk populations.

RouteDoseNumber of dosesSchedule
Intramuscular1 ml3Day 0, 7 & 21 or 28
Intradermal0.1 ml3Day 0, 7 & 21 or 28

The following schedule should be followed for post-exposure prophylaxis in previously unimmunized individuals.

RouteDoseNumber of dosesSchedule
Intramuscular1 ml5Day 0, 3, 7, 14 & 28
Intradermal0.1 ml4Day 0, 3, 7 & 28

In case an individual who has been fully immunized in the past is exposed to Rabies, the recommended PEP schedule is one dose of Rabies vaccine injected intramuscularly (1 ml) or intradermally (0.1 ml) on day 0 and day 3

PRESENTATION:

  • 1 dose - 1 ml vial plus diluent

DTPVAC

Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) I.P

INDICATION

Indicated for infants above the age of six weeks and of pre-school children against diphtheria, tetanus and pertussis (whooping cough).

ROUTE OF ADMINISTRATION

Intramuscular Injection

IMMUNIZATION SCHEDULE

First 3 doses should be given 4 weeks apart at 6, 10 and 14 weeks.

A booster dose can be given at the age of 15-18 months and also between the ages of 4 to 6 years.

COMPOSITION

  • Each single 0.5 ml dose contains

  • Diphtheria Toxoid ≤ 25 Lf (≥ 30 IU)

  • Tetanus Toxoid ≥ 5 Lf (≥ 40 IU)

  • B. Pertussis ≤ 16 OU (≥ 4 IU)

  • Adsorbed on Aluminium Phosphate, Al+++ ≤ 1.25 mg

  • Preservative: 0.005% Thiomersal

PRESENTATION:

  • Box of 10 ampoules of 0.5 ml each

  • Box of 10 MD vials of 5 ml each